Published in Blood on August 24, 2011
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle (2013) 1.33
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. J Invest Dermatol (2013) 1.15
MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ Health Perspect (2015) 1.13
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer. PLoS One (2013) 1.09
Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep (2015) 1.06
Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle (2014) 0.97
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma. Toxins (Basel) (2013) 0.91
Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. Lab Invest (2015) 0.91
Control by a hair's breadth: the role of microRNAs in the skin. Cell Mol Life Sci (2012) 0.90
Involvement of MicroRNA in T-Cell Differentiation and Malignancy. Int J Hematol Oncol Stem Cell Res (2015) 0.88
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag Res (2012) 0.88
miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1. Oncotarget (2015) 0.87
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma. J Invest Dermatol (2014) 0.87
Lessons learned from gene expression profiling of cutaneous T-cell lymphoma. Br J Dermatol (2013) 0.87
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma. Oncotarget (2015) 0.84
Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma. Oncotarget (2015) 0.84
Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155. Cell Cycle (2013) 0.83
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Oncotarget (2015) 0.83
IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle (2014) 0.82
μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix. BMC Bioinformatics (2013) 0.81
MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol (2013) 0.80
Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog (2014) 0.80
Early CTCL diagnosis, a (miR)age no more? Blood (2011) 0.79
MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation. PLoS One (2013) 0.79
BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma. Leukemia (2015) 0.78
Keeping each other in check: a reciprocal relationship between cytokines and miRNA. Cell Cycle (2013) 0.78
IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function. J Immunol (2016) 0.78
Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells. PLoS One (2014) 0.78
MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential. Curr Genomics (2015) 0.78
Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci Rep (2016) 0.77
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome. J Invest Dermatol (2015) 0.77
Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine. Inflamm Bowel Dis (2015) 0.76
miR-155 meets the JAK/STAT pathway. Cell Cycle (2013) 0.76
Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology (2017) 0.75
Genetics: New miRNA classifier distinguishes CTCL from benign skin disorders. Nat Rev Clin Oncol (2011) 0.75
STAT5 induces miR-21 expression in cutaneous T cell lymphoma. Oncotarget (2016) 0.75
MicroRNA-711 is a prognostic factor for poor overall survival and has an oncogenic role in breast cancer. Oncol Lett (2016) 0.75
Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol (2014) 0.75
The role of molecular pathology in the diagnosis of cutaneous lymphomas. Patholog Res Int (2012) 0.75
RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression. Oncotarget (2016) 0.75
MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients. Leuk Res (2016) 0.75
TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform. Front Med (Lausanne) (2017) 0.75
The biomarker landscape in mycosis fungoides and sézary syndrome. Exp Dermatol (2016) 0.75
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
MicroRNAs in Cancer. Annu Rev Med (2009) 9.37
A comparison of background correction methods for two-colour microarrays. Bioinformatics (2007) 8.59
MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol (2008) 7.27
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell (2008) 4.01
MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One (2007) 3.96
MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol (2008) 2.23
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood (2009) 2.16
Leukaemogenesis: more than mutant genes. Nat Rev Cancer (2010) 2.16
Peripheral T-cell lymphoma. Blood (2011) 2.11
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood (2010) 1.88
miRNA control of tumor cell invasion and metastasis. Int J Cancer (2010) 1.79
The pathogenesis of mycosis fungoides. N Engl J Med (2004) 1.78
Defining early mycosis fungoides. J Am Acad Dermatol (2005) 1.78
Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med (2009) 1.73
Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood (2008) 1.56
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood (2006) 1.46
In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia (2004) 1.44
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer (2006) 1.38
Global microRNA analysis of the NCI-60 cancer cell panel. Mol Cancer Ther (2011) 1.34
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia (2006) 1.31
MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. J Invest Dermatol (2010) 1.31
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia (2005) 1.31
MicroRNAs: novel regulators in skin inflammation. Clin Exp Dermatol (2008) 1.29
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia (2007) 1.24
MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci (2010) 1.24
The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control (2007) 1.17
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma. Blood (2009) 1.15
The expression of microRNA-203 during human skin morphogenesis. Exp Dermatol (2010) 1.04
Steroid receptor and microRNA regulation in cancer. Curr Opin Oncol (2010) 1.04
miRNA expression profiling of mycosis fungoides. Mol Oncol (2011) 1.01
A novel xenograft model of cutaneous T-cell lymphoma. Exp Dermatol (2010) 0.99
Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol (2002) 0.98
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br J Dermatol (2008) 0.98
Criterion by criterion, mycosis fungoides. Am J Dermatopathol (2003) 0.98
Deficient SOCS3 and SHP-1 expression in psoriatic T cells. J Invest Dermatol (2010) 0.97
Primary cutaneous T-cell lymphomas. Hematology Am Soc Hematol Educ Program (2006) 0.96
Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol (1999) 0.95
Reproducible pattern of microRNA in normal human skin. Exp Dermatol (2010) 0.92
COX-2 is a novel target in therapy of mycosis fungoides. Leukemia (2010) 0.88
Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model. J Transl Med (2009) 0.87
Targeted therapies: Denileukin diftitox--a step towards a 'magic bullet' for CTCL. Nat Rev Clin Oncol (2010) 0.84
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol (2006) 4.72
Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science (2004) 3.66
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med (2012) 3.14
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci U S A (2008) 2.99
Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol (2010) 2.55
Knockout of Arabidopsis accelerated-cell-death11 encoding a sphingosine transfer protein causes activation of programmed cell death and defense. Genes Dev (2002) 2.51
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J (2011) 2.30
Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatol (2013) 2.18
Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children. Arch Dermatol (2006) 2.16
Cell motility as persistent random motion: theories from experiments. Biophys J (2005) 2.00
Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing. RNA (2009) 1.96
Increased sensitivity to interferon-alpha in psoriatic T cells. J Invest Dermatol (2005) 1.95
IKK beta is required for peripheral B cell survival and proliferation. J Immunol (2003) 1.92
Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J Immunol (2002) 1.89
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis (2010) 1.87
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol (2012) 1.87
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3. Lab Invest (2005) 1.86
Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol (2003) 1.81
STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A (2005) 1.80
Ligand-independent activation of the EGFR by lipid raft disruption. J Invest Dermatol (2006) 1.78
Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med (2009) 1.73
Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res (2005) 1.73
Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway. J Invest Dermatol (2011) 1.70
Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv (2009) 1.69
Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A (2004) 1.69
Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle. Proc Natl Acad Sci U S A (2002) 1.68
Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev (2007) 1.65
The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res (2012) 1.61
Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J Biol Chem (2003) 1.59
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol (2008) 1.58
Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood (2012) 1.57
Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg (2009) 1.57
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood (2006) 1.56
MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. J Invest Dermatol (2008) 1.54
Advances in DNA methylation: 5-hydroxymethylcytosine revisited. Clin Chim Acta (2011) 1.54
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. Proc Natl Acad Sci U S A (2006) 1.53
STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nat Med (2007) 1.53
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv (2013) 1.48
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur. Br J Haematol (2012) 1.48
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer (2011) 1.46
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood (2006) 1.46
Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study. Ann Intern Med (2016) 1.46
Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma. Eur J Haematol (2007) 1.46
Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res (2007) 1.45
The importance of Notch signaling in peripheral T-cell lymphomas. Leuk Lymphoma (2013) 1.45
Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant (2007) 1.41
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica (2013) 1.40
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest (2003) 1.37
Global microRNA analysis of the NCI-60 cancer cell panel. Mol Cancer Ther (2011) 1.34
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol (2002) 1.33
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle (2013) 1.33
Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg (2009) 1.30
Hybrid approaches to thoracic aortic aneurysms: the role of endovascular elephant trunk completion. Circulation (2005) 1.26
Melanoma diagnosis by Raman spectroscopy and neural networks: structure alterations in proteins and lipids in intact cancer tissue. J Invest Dermatol (2004) 1.24
MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci (2010) 1.24
Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells. Cancer Res (2008) 1.23
A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins. Cancer Res (2004) 1.23
Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol (2009) 1.21
A new CT method for measuring cup orientation after total hip arthroplasty: a study of 10 patients. Acta Orthop Scand (2004) 1.20
Lipocalin 2 is protective against E. coli pneumonia. Respir Res (2010) 1.19
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation (2008) 1.18
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology (2007) 1.18
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood (2011) 1.17
Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood (2002) 1.16
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood (2013) 1.16